- Home
- TAOP vs OGEN Comparison
TAOP vs OGEN Comparison
Compare TAOP & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- OGEN
- Stock Information
- Founded
- TAOP 1993
- OGEN 1996
- Country
- TAOP China
- OGEN United States
- Employees
- TAOP N/A
- OGEN N/A
- Industry
- TAOP Computer Software: Prepackaged Software
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- TAOP Technology
- OGEN Health Care
- Exchange
- TAOP Nasdaq
- OGEN Nasdaq
- Market Cap
- TAOP 3.3M
- OGEN 3.9M
- IPO Year
- TAOP N/A
- OGEN N/A
- Fundamental
- Price
- TAOP $0.32
- OGEN $0.29
- Analyst Decision
- TAOP
- OGEN
- Analyst Count
- TAOP 0
- OGEN 0
- Target Price
- TAOP N/A
- OGEN N/A
- AVG Volume (30 Days)
- TAOP 983.2K
- OGEN 14.3M
- Earning Date
- TAOP 09-05-2024
- OGEN 03-28-2025
- Dividend Yield
- TAOP N/A
- OGEN N/A
- EPS Growth
- TAOP N/A
- OGEN N/A
- EPS
- TAOP 0.50
- OGEN N/A
- Revenue
- TAOP $42,636,173.00
- OGEN N/A
- Revenue This Year
- TAOP N/A
- OGEN N/A
- Revenue Next Year
- TAOP N/A
- OGEN N/A
- P/E Ratio
- TAOP $0.50
- OGEN N/A
- Revenue Growth
- TAOP 37.49
- OGEN N/A
- 52 Week Low
- TAOP $0.23
- OGEN $0.25
- 52 Week High
- TAOP $1.39
- OGEN $3.84
- Technical
- Relative Strength Index (RSI)
- TAOP 54.56
- OGEN 46.16
- Support Level
- TAOP $0.28
- OGEN $0.28
- Resistance Level
- TAOP $0.34
- OGEN $0.31
- Average True Range (ATR)
- TAOP 0.03
- OGEN 0.05
- MACD
- TAOP 0.01
- OGEN 0.00
- Stochastic Oscillator
- TAOP 75.50
- OGEN 9.39
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.